GenSpera, Inc. (GNSZ), a leader in developing prod
Post# of 98051
Posted On: 08/14/2014 11:50:35 AM
GenSpera, Inc. (GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces it will be presenting at the Rodman & Renshaw 16th Annual Global Investment Conference. The conference will be held September 8-10, 2014 at the New York Palace Hotel in New York.
The conference is attended by public companies, institutional investors, sophisticated private investors and industry executives.
Read more at:
http://stockpumpers.blogspot.com/2014/08/gnsz.html
The conference is attended by public companies, institutional investors, sophisticated private investors and industry executives.
Read more at:
http://stockpumpers.blogspot.com/2014/08/gnsz.html
(0)
(0)Scroll down for more posts ▼